Orange Book product · Generic (ANDA)
ALPRAZOLAM
ALPRAZOLAM
At a glance
Oct 19, 1993
Approved
Generic (ANDA)
Application
Not listed
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Oct 19, 1993
33 yr 2 mo ago
Today
Pharmaceutical detail
Active ingredient
ALPRAZOLAM
Strength
0.25MG
Dosage form
TABLET
Route
ORAL
TE code
Not listed
Application
ANDA 074199
Product number
001
Marketing status
DISCN
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of ALPRAZOLAM
- 2005NIRAVAMBrand (NDA)
NDA 021726 · UCB INC
- 2003XANAX XRBrand (NDA)
NDA 021434 · UPJOHN
- —XANAXBrand (NDA)
NDA 018276 · UPJOHN
- 2018ALPRAZOLAMGeneric (ANDA)
ANDA 207507 · CHARTWELL RX
- 2015ALPRAZOLAMGeneric (ANDA)
ANDA 203346 · AUROBINDO PHARMA
- 2015ALPRAZOLAMGeneric (ANDA)
ANDA 200739 · NATCO
- 2011ALPRAZOLAMGeneric (ANDA)
ANDA 078469 · PH HEALTH
- 2011ALPRAZOLAMGeneric (ANDA)
ANDA 090871 · AUROBINDO PHARMA
- 2010ALPRAZOLAMGeneric (ANDA)
ANDA 090248 · STRIDES PHARMA INTL
- 2010ALPRAZOLAMGeneric (ANDA)
ANDA 090082 · SUN PHARM
- 2010ALPRAZOLAMGeneric (ANDA)
ANDA 077198 · ACTAVIS LABS FL INC
- 2010ALPRAZOLAMGeneric (ANDA)
ANDA 078561 · ACTAVIS ELIZABETH
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
